RAPID CTP: fully-automated perfusion maps; accurately quantifies reduced cerebral blood flow, cerebral blood volume and transit time
RAPID MRI: fully-automated diffusion and perfusion maps that quantify brain areas with low ADC values, as well as delayed contrast arrival
RAPID CTA: automatically delivers CT angiography maps and identifies brain regions with reduced blood vessel density in 2D and 3D outputs
RAPID ASPECTS: automatically identifies areas of early ischemic change on non-contrast CT scans, which predicts irreversible injury

RAPID ICH: automatically triages non-contrast CT scans to quickly identify brain hemorrhages with a sensitivity and specificity >90%
RAPID Mobile: securely preview RAPID results from multiple sites with customizable notifications on mobile devices
“The innovative technology used in RAPID ICH taps into the latest in artificial intelligence to help clinicians make life saving decisions,” said Don Listwin, CEO of iSchemaView. “RAPID ICH’s highly accurate detection of possible intracranial hemorrhages expands RAPID’s offerings past ischemic events to also include hemorrhagic. In the end, this gives stroke care teams the ability to successfully identify and treat more stroke patients than ever before.”


About RAPID
RAPID is the worldwide leader in advanced imaging for stroke. Installed in over 1,300 hospitals, RAPID (automated CTP, MRI, CTA, ICH and ASPECTS), with enhanced AI framework, is the most advanced stroke imaging platform. In clinical trials, RAPID has been shown to aid in the selection of patients in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, these landmark studies led to new American Heart Association and American Stroke Association guidelines and have dramatically altered the management of acute stroke around the world.

Back to HCB News

Cardiology Homepage